These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12198819)

  • 1. Angiotensin-converting enzyme inhibitors: are there credible mechanisms for beneficial effects in diabetic neuropathy?
    Malik RA; Tomlinson DR
    Int Rev Neurobiol; 2002; 50():415-30. PubMed ID: 12198819
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a link between the circulating renin-angiotensin system and coronary disease? A sceptical view.
    Swales JD
    Heart; 1996 Nov; 76(3 Suppl 3):23-7. PubMed ID: 8977362
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic innervation of vasa and nervi nervorum of optic, sciatic, vagus and sympathetic nerve trunks in normal and streptozotocin-diabetic rats.
    Dhital K; Lincoln J; Appenzeller O; Burnstock G
    Brain Res; 1986 Mar; 367(1-2):39-44. PubMed ID: 2938665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural changes in blood vessels of peripheral nerves in leprosy neuropathy. II. Borderline, borderline-lepromatous and lepromatous leprosy patients.
    Boddingius J
    Acta Neuropathol; 1977 Sep; 40(1):21-39. PubMed ID: 199033
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of the renin-angiotensin system in essential hypertension.
    Paran E; Nemenoff RA; Schrier RW
    Curr Opin Nephrol Hypertens; 1995 Jul; 4(4):295-9. PubMed ID: 7552093
    [No Abstract]   [Full Text] [Related]  

  • 6. The renin-angiotensin-aldosterone system and cardiac ischaemia.
    Ikram H
    Heart; 1996 Nov; 76(3 Suppl 3):60-7. PubMed ID: 8983666
    [No Abstract]   [Full Text] [Related]  

  • 7. Anesthetic implications of the renin-angiotensin system and angiotensin-converting enzyme inhibitors.
    Mirenda JV; Grissom TE
    Anesth Analg; 1991 May; 72(5):667-83. PubMed ID: 2018225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vascular wall renin-angiotensin system as a target of therapeutic interventions].
    Karpov IuA
    Kardiologiia; 2003; 43(5):82-6. PubMed ID: 12942932
    [No Abstract]   [Full Text] [Related]  

  • 9. Manipulation of the renin angiotensin system in peripheral arterial disease.
    Hobbs SD; Thomas ME; Bradbury AW
    Eur J Vasc Endovasc Surg; 2004 Dec; 28(6):573-82. PubMed ID: 15531190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction: the hemodynamic and vascular effects of angiotensin II: managing the consequences.
    Weber MA
    Am J Hypertens; 2002 Jan; 15(1 Pt 2):1S-2S. PubMed ID: 11824871
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors.
    Ganten D; Mullins J; Lindpaintner K
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():63-70. PubMed ID: 2674443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular renin-angiotensin system and vascular protection.
    Dzau VJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S1-9. PubMed ID: 7508045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiotensin-converting enzyme inhibitors: effects on renal physiology and applications in hypertension and renal disease].
    Cofán F; Romero R
    Rev Clin Esp; 1993 Jan; 192(1):31-8. PubMed ID: 8465029
    [No Abstract]   [Full Text] [Related]  

  • 17. Renin angiotensin system antagonists and anesthesia.
    Colson P; Ryckwaert F; Coriat P
    Anesth Analg; 1999 Nov; 89(5):1143-55. PubMed ID: 10553825
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin II as an inflammatory mediator: evolving concepts in the role of the renin angiotensin system in the failing heart.
    Mann DL
    Cardiovasc Drugs Ther; 2002 Jan; 16(1):7-9. PubMed ID: 12085982
    [No Abstract]   [Full Text] [Related]  

  • 19. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J; Chaturvedi N
    Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers.
    Weir MR; Henrich WL
    Curr Opin Nephrol Hypertens; 2000 Jul; 9(4):403-11. PubMed ID: 10926177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.